Pharma stocks slide after new tweet from Trump on drug prices
Share of Eli Lilly and Co. and numerous other drug industry stocks fell Tuesday morning after the president sent a tweet promising to lower medicine costs for American people.
Bloomberg News
Articles
Department store chain Gordmans facing bankruptcy
Gordmans Stores Inc., a Midwestern department-store chain founded more than a century ago, is preparing to file for bankruptcy, according to people familiar with the matter. The retailer has one store in the Indianapolis area and several others in Indiana.
HHGregg could file bankruptcy as soon as next week
The news comes one day after the Indianapolis-based retailer announced that it was closing 88 stores and three distribution centers
Chinese firm working with Lilly gets positive results on cancer drug
Hutchison China MediTech Ltd., the biotechnology company that has a partnership with Eli Lilly and Co., on Friday reported positive late-stage results for its drug to treat colorectal cancer.
RadioShack’s successor reportedly preparing for bankruptcy
A filing could happen within the coming days and will probably result in liquidation, sources said. The Indianapolis area is still home to several RadioShack locations.
Drug companies willing to spend big in pursuit of Alzheimer’s cure
Alzheimer’s disease is rewriting the rules of drug discovery, with companies like Eli Lilly and others abandoning caution to keep pursuing an elusive hypothesis because the potential payoff is so great.
Subaru’s ‘spiritual’ message spurs U.S. sales as rivals use discounts
With almost all carmakers heaping on the discounts to keep the U.S. auto market at a plateau, Subaru just notched its 63rd straight monthly sales gain, with minimal incentives to get customers in the door.
Coats promises he’ll provide Trump with nonpolitical intelligence
Dan Coats sought to tamp down tensions between President Donald Trump and U.S. intelligence agencies, assuring former Senate colleagues at his confirmation hearing that he would act independently as director of national intelligence.
Coats caught in middle as Trump takes on intelligence agencies
Former Indiana Sen. Dan Coats is likely to face tough questioning because President Donald Trump has nominated him to supervise the nation’s 17 intelligence agencies while they’re mired in explosive investigations.
U.S. farms swapping corn for soybeans as profit margin widens
While corn is still king, farmers from North Dakota to Texas are preparing to use more of their land on soybeans instead. And the reason why is obvious.
Anthem, Cigna blast one another over blocked insurer merger
Cigna Corp. and Anthem Inc. are trading accusations of harassment and sabotage in competing lawsuits as the two health companies feud publicly in the wake of a stalled $48 billion merger.
Judge blocks Cigna from scuttling $48 billion deal with Anthem
Indianapolis-based Anthem Inc. on Wednesday won a court ruling blocking Cigna Corp. from terminating a proposed merger between the health insurers until a judge could weigh arguments over the faltering deal at an April 10 hearing.
Merck stops Alzheimer’s study after ‘no chance’ of benefit
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
Cigna seeks to terminate merger with Anthem, sues insurer for $13B
Indianapolis-based Anthem responded almost immediately Tuesday by saying Cigna does not have the right to cancel the deal.
Yellen sees more rate hikes ahead if economy stays on course
Federal Reserve Chairwoman Janet Yellen said more interest-rate increases will be appropriate if the U.S. economy meets the central bank’s outlook of gradually rising inflation and tightening labor markets.
Aetna gives up on $34B Humana deal, will pay $1B breakup fee
The Humana-Aetna deal was one of two mergers that would have reshaped the U.S. health insurance landscape. Both were rejected by federal judges as anticompetitive. Anthem hasn't given up on its deal—a $48 billion pact to acquire Cigna—and is pressing ahead with an appeal.
After megadeals blocked, health insurers plotting next moves
Anthem filed a notice of appeal on Thursday after a federal judge blocked its $48 billion deal to buy Cigna Corp.
Dying patients have Pence’s backing on ‘right to try’ policy
Vice President Mike Pence may have just picked another fight with pharmaceutical companies—one that doesn’t involve drug prices.
Anthem’s $48B bid for Cigna blocked by judge as anticompetitive
The deal, along with Aetna Inc.’s proposed tie-up with Humana Inc., which was blocked last month, was set to reduce the ranks of big U.S. health insurers to three from five and make Anthem the largest by membership.
More employers starting to deal with death, dying in benefits packages
Companies have spent the last few years beefing up their parental-leave policies to attract and retain the most sought-after workers. Up next in the benefits arms race: helping workers deal with sickness and death.